nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Gastrointestinal tract irritation—Alendronate—osteoporosis	0.0633	0.0633	CcSEcCtD
Metaxalone—Gastrointestinal tract irritation—Ibandronate—osteoporosis	0.0616	0.0616	CcSEcCtD
Metaxalone—Gastrointestinal tract irritation—Risedronate—osteoporosis	0.0508	0.0508	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Estropipate—osteoporosis	0.0172	0.0172	CcSEcCtD
Metaxalone—Irritability—Estropipate—osteoporosis	0.0159	0.0159	CcSEcCtD
Metaxalone—Abdominal discomfort—Estropipate—osteoporosis	0.0138	0.0138	CcSEcCtD
Metaxalone—Abdominal discomfort—Alendronate—osteoporosis	0.0136	0.0136	CcSEcCtD
Metaxalone—Abdominal discomfort—Ibandronate—osteoporosis	0.0132	0.0132	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Pamidronate—osteoporosis	0.0129	0.0129	CcSEcCtD
Metaxalone—Irritability—Ethinyl Estradiol—osteoporosis	0.0129	0.0129	CcSEcCtD
Metaxalone—Drowsiness—Calcitriol—osteoporosis	0.012	0.012	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.0114	0.0114	CcSEcCtD
Metaxalone—Abdominal discomfort—Risedronate—osteoporosis	0.0109	0.0109	CcSEcCtD
Metaxalone—Hypersensitivity—Calcium Acetate—osteoporosis	0.0106	0.0106	CcSEcCtD
Metaxalone—Irritability—Conjugated Estrogens—osteoporosis	0.0105	0.0105	CcSEcCtD
Metaxalone—Leukopenia—Etidronic acid—osteoporosis	0.0104	0.0104	CcSEcCtD
Metaxalone—Pruritus—Calcium Acetate—osteoporosis	0.0102	0.0102	CcSEcCtD
Metaxalone—Tension—Estropipate—osteoporosis	0.00984	0.00984	CcSEcCtD
Metaxalone—Nervousness—Estropipate—osteoporosis	0.00974	0.00974	CcSEcCtD
Metaxalone—Dizziness—Calcium Acetate—osteoporosis	0.00953	0.00953	CcSEcCtD
Metaxalone—Abdominal discomfort—Zoledronate—osteoporosis	0.00947	0.00947	CcSEcCtD
Metaxalone—Vomiting—Calcium Acetate—osteoporosis	0.00916	0.00916	CcSEcCtD
Metaxalone—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.00912	0.00912	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Estradiol—osteoporosis	0.0091	0.0091	CcSEcCtD
Metaxalone—Nausea—Calcium Acetate—osteoporosis	0.00856	0.00856	CcSEcCtD
Metaxalone—Irritability—Estradiol—osteoporosis	0.00841	0.00841	CcSEcCtD
Metaxalone—Anaphylactic shock—Estropipate—osteoporosis	0.00818	0.00818	CcSEcCtD
Metaxalone—Anaphylactic shock—Ibandronate—osteoporosis	0.00785	0.00785	CcSEcCtD
Metaxalone—Anaphylactic shock—Calcitriol—osteoporosis	0.00768	0.00768	CcSEcCtD
Metaxalone—Nausea—Ergocalciferol—osteoporosis	0.00756	0.00756	CcSEcCtD
Metaxalone—Tension—Pamidronate—osteoporosis	0.00739	0.00739	CcSEcCtD
Metaxalone—Nervousness—Pamidronate—osteoporosis	0.00732	0.00732	CcSEcCtD
Metaxalone—Abdominal discomfort—Estradiol—osteoporosis	0.0073	0.0073	CcSEcCtD
Metaxalone—Somnolence—Estropipate—osteoporosis	0.00728	0.00728	CcSEcCtD
Metaxalone—Hypersensitivity—Etidronic acid—osteoporosis	0.00697	0.00697	CcSEcCtD
Metaxalone—Somnolence—Calcitriol—osteoporosis	0.00683	0.00683	CcSEcCtD
Metaxalone—Leukopenia—Pamidronate—osteoporosis	0.00674	0.00674	CcSEcCtD
Metaxalone—Pruritus—Etidronic acid—osteoporosis	0.00669	0.00669	CcSEcCtD
Metaxalone—Jaundice—Estradiol—osteoporosis	0.00662	0.00662	CcSEcCtD
Metaxalone—Tension—Conjugated Estrogens—osteoporosis	0.0065	0.0065	CcSEcCtD
Metaxalone—Nervousness—Conjugated Estrogens—osteoporosis	0.00644	0.00644	CcSEcCtD
Metaxalone—Leukopenia—Zoledronate—osteoporosis	0.00616	0.00616	CcSEcCtD
Metaxalone—Anaphylactic shock—Pamidronate—osteoporosis	0.00615	0.00615	CcSEcCtD
Metaxalone—Hypersensitivity—Estropipate—osteoporosis	0.00603	0.00603	CcSEcCtD
Metaxalone—Vomiting—Etidronic acid—osteoporosis	0.00602	0.00602	CcSEcCtD
Metaxalone—Rash—Etidronic acid—osteoporosis	0.00597	0.00597	CcSEcCtD
Metaxalone—Dermatitis—Etidronic acid—osteoporosis	0.00596	0.00596	CcSEcCtD
Metaxalone—Hypersensitivity—Alendronate—osteoporosis	0.00594	0.00594	CcSEcCtD
Metaxalone—Headache—Etidronic acid—osteoporosis	0.00593	0.00593	CcSEcCtD
Metaxalone—Pruritus—Estropipate—osteoporosis	0.00579	0.00579	CcSEcCtD
Metaxalone—Hypersensitivity—Ibandronate—osteoporosis	0.00578	0.00578	CcSEcCtD
Metaxalone—Pruritus—Alendronate—osteoporosis	0.0057	0.0057	CcSEcCtD
Metaxalone—Hypersensitivity—Calcitriol—osteoporosis	0.00566	0.00566	CcSEcCtD
Metaxalone—Nausea—Etidronic acid—osteoporosis	0.00562	0.00562	CcSEcCtD
Metaxalone—Anaphylactic shock—Zoledronate—osteoporosis	0.00562	0.00562	CcSEcCtD
Metaxalone—Pruritus—Ibandronate—osteoporosis	0.00555	0.00555	CcSEcCtD
Metaxalone—Somnolence—Pamidronate—osteoporosis	0.00547	0.00547	CcSEcCtD
Metaxalone—Pruritus—Calcitriol—osteoporosis	0.00544	0.00544	CcSEcCtD
Metaxalone—Dizziness—Estropipate—osteoporosis	0.00541	0.00541	CcSEcCtD
Metaxalone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00541	0.00541	CcSEcCtD
Metaxalone—Dizziness—Alendronate—osteoporosis	0.00533	0.00533	CcSEcCtD
Metaxalone—Dizziness—Raloxifene—osteoporosis	0.00524	0.00524	CcSEcCtD
Metaxalone—Tension—Estradiol—osteoporosis	0.0052	0.0052	CcSEcCtD
Metaxalone—Vomiting—Estropipate—osteoporosis	0.0052	0.0052	CcSEcCtD
Metaxalone—Dizziness—Ibandronate—osteoporosis	0.00519	0.00519	CcSEcCtD
Metaxalone—Rash—Estropipate—osteoporosis	0.00516	0.00516	CcSEcCtD
Metaxalone—Dermatitis—Estropipate—osteoporosis	0.00516	0.00516	CcSEcCtD
Metaxalone—Nervousness—Estradiol—osteoporosis	0.00515	0.00515	CcSEcCtD
Metaxalone—Headache—Estropipate—osteoporosis	0.00513	0.00513	CcSEcCtD
Metaxalone—Vomiting—Alendronate—osteoporosis	0.00513	0.00513	CcSEcCtD
Metaxalone—Rash—Alendronate—osteoporosis	0.00508	0.00508	CcSEcCtD
Metaxalone—Dermatitis—Alendronate—osteoporosis	0.00508	0.00508	CcSEcCtD
Metaxalone—Headache—Alendronate—osteoporosis	0.00505	0.00505	CcSEcCtD
Metaxalone—Vomiting—Raloxifene—osteoporosis	0.00504	0.00504	CcSEcCtD
Metaxalone—Rash—Raloxifene—osteoporosis	0.005	0.005	CcSEcCtD
Metaxalone—Dermatitis—Raloxifene—osteoporosis	0.00499	0.00499	CcSEcCtD
Metaxalone—Somnolence—Zoledronate—osteoporosis	0.00499	0.00499	CcSEcCtD
Metaxalone—Vomiting—Ibandronate—osteoporosis	0.00499	0.00499	CcSEcCtD
Metaxalone—Headache—Raloxifene—osteoporosis	0.00497	0.00497	CcSEcCtD
Metaxalone—Rash—Ibandronate—osteoporosis	0.00495	0.00495	CcSEcCtD
Metaxalone—Dermatitis—Ibandronate—osteoporosis	0.00494	0.00494	CcSEcCtD
Metaxalone—Headache—Ibandronate—osteoporosis	0.00492	0.00492	CcSEcCtD
Metaxalone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00489	0.00489	CcSEcCtD
Metaxalone—Vomiting—Calcitriol—osteoporosis	0.00489	0.00489	CcSEcCtD
Metaxalone—Nausea—Estropipate—osteoporosis	0.00486	0.00486	CcSEcCtD
Metaxalone—Rash—Calcitriol—osteoporosis	0.00484	0.00484	CcSEcCtD
Metaxalone—Dermatitis—Calcitriol—osteoporosis	0.00484	0.00484	CcSEcCtD
Metaxalone—Headache—Calcitriol—osteoporosis	0.00481	0.00481	CcSEcCtD
Metaxalone—Somnolence—Conjugated Estrogens—osteoporosis	0.00481	0.00481	CcSEcCtD
Metaxalone—Nausea—Alendronate—osteoporosis	0.00479	0.00479	CcSEcCtD
Metaxalone—Hypersensitivity—Risedronate—osteoporosis	0.00477	0.00477	CcSEcCtD
Metaxalone—Nausea—Raloxifene—osteoporosis	0.00471	0.00471	CcSEcCtD
Metaxalone—Pruritus—Ethinyl Estradiol—osteoporosis	0.00469	0.00469	CcSEcCtD
Metaxalone—Nausea—Ibandronate—osteoporosis	0.00466	0.00466	CcSEcCtD
Metaxalone—Pruritus—Risedronate—osteoporosis	0.00458	0.00458	CcSEcCtD
Metaxalone—Nausea—Calcitriol—osteoporosis	0.00456	0.00456	CcSEcCtD
Metaxalone—Hypersensitivity—Pamidronate—osteoporosis	0.00453	0.00453	CcSEcCtD
Metaxalone—Dizziness—Ethinyl Estradiol—osteoporosis	0.00439	0.00439	CcSEcCtD
Metaxalone—Pruritus—Pamidronate—osteoporosis	0.00435	0.00435	CcSEcCtD
Metaxalone—Anaphylactic shock—Estradiol—osteoporosis	0.00433	0.00433	CcSEcCtD
Metaxalone—Dizziness—Risedronate—osteoporosis	0.00428	0.00428	CcSEcCtD
Metaxalone—Vomiting—Ethinyl Estradiol—osteoporosis	0.00422	0.00422	CcSEcCtD
Metaxalone—Rash—Ethinyl Estradiol—osteoporosis	0.00418	0.00418	CcSEcCtD
Metaxalone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00418	0.00418	CcSEcCtD
Metaxalone—Headache—Ethinyl Estradiol—osteoporosis	0.00416	0.00416	CcSEcCtD
Metaxalone—Hypersensitivity—Zoledronate—osteoporosis	0.00414	0.00414	CcSEcCtD
Metaxalone—Vomiting—Risedronate—osteoporosis	0.00411	0.00411	CcSEcCtD
Metaxalone—Rash—Risedronate—osteoporosis	0.00408	0.00408	CcSEcCtD
Metaxalone—Dermatitis—Risedronate—osteoporosis	0.00407	0.00407	CcSEcCtD
Metaxalone—Dizziness—Pamidronate—osteoporosis	0.00407	0.00407	CcSEcCtD
Metaxalone—Headache—Risedronate—osteoporosis	0.00405	0.00405	CcSEcCtD
Metaxalone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00398	0.00398	CcSEcCtD
Metaxalone—Pruritus—Zoledronate—osteoporosis	0.00397	0.00397	CcSEcCtD
Metaxalone—Nausea—Ethinyl Estradiol—osteoporosis	0.00394	0.00394	CcSEcCtD
Metaxalone—Vomiting—Pamidronate—osteoporosis	0.00391	0.00391	CcSEcCtD
Metaxalone—Rash—Pamidronate—osteoporosis	0.00388	0.00388	CcSEcCtD
Metaxalone—Dermatitis—Pamidronate—osteoporosis	0.00387	0.00387	CcSEcCtD
Metaxalone—Headache—Pamidronate—osteoporosis	0.00385	0.00385	CcSEcCtD
Metaxalone—Somnolence—Estradiol—osteoporosis	0.00385	0.00385	CcSEcCtD
Metaxalone—Nausea—Risedronate—osteoporosis	0.00384	0.00384	CcSEcCtD
Metaxalone—Pruritus—Conjugated Estrogens—osteoporosis	0.00383	0.00383	CcSEcCtD
Metaxalone—Dizziness—Zoledronate—osteoporosis	0.00371	0.00371	CcSEcCtD
Metaxalone—Nausea—Pamidronate—osteoporosis	0.00365	0.00365	CcSEcCtD
Metaxalone—Dizziness—Conjugated Estrogens—osteoporosis	0.00358	0.00358	CcSEcCtD
Metaxalone—Vomiting—Zoledronate—osteoporosis	0.00357	0.00357	CcSEcCtD
Metaxalone—Rash—Zoledronate—osteoporosis	0.00354	0.00354	CcSEcCtD
Metaxalone—Dermatitis—Zoledronate—osteoporosis	0.00354	0.00354	CcSEcCtD
Metaxalone—Headache—Zoledronate—osteoporosis	0.00352	0.00352	CcSEcCtD
Metaxalone—Vomiting—Conjugated Estrogens—osteoporosis	0.00344	0.00344	CcSEcCtD
Metaxalone—Rash—Conjugated Estrogens—osteoporosis	0.00341	0.00341	CcSEcCtD
Metaxalone—Dermatitis—Conjugated Estrogens—osteoporosis	0.00341	0.00341	CcSEcCtD
Metaxalone—Headache—Conjugated Estrogens—osteoporosis	0.00339	0.00339	CcSEcCtD
Metaxalone—Nausea—Zoledronate—osteoporosis	0.00334	0.00334	CcSEcCtD
Metaxalone—Nausea—Conjugated Estrogens—osteoporosis	0.00321	0.00321	CcSEcCtD
Metaxalone—Hypersensitivity—Estradiol—osteoporosis	0.00319	0.00319	CcSEcCtD
Metaxalone—Pruritus—Estradiol—osteoporosis	0.00306	0.00306	CcSEcCtD
Metaxalone—Dizziness—Estradiol—osteoporosis	0.00286	0.00286	CcSEcCtD
Metaxalone—Vomiting—Estradiol—osteoporosis	0.00275	0.00275	CcSEcCtD
Metaxalone—Rash—Estradiol—osteoporosis	0.00273	0.00273	CcSEcCtD
Metaxalone—Dermatitis—Estradiol—osteoporosis	0.00273	0.00273	CcSEcCtD
Metaxalone—Headache—Estradiol—osteoporosis	0.00271	0.00271	CcSEcCtD
Metaxalone—Nausea—Estradiol—osteoporosis	0.00257	0.00257	CcSEcCtD
